Entero Therapeutics, Inc. (ENTO)
(Delayed Data from NSDQ)
$0.44 USD
+0.03 (6.59%)
Updated Aug 6, 2025 03:53 PM ET
After-Market: $0.42 -0.02 (-4.55%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Entero Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ENTO 0.44 +0.03(6.59%)
Will ENTO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENTO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ENTO
US Stocks Likely To Open Higher: Trump's Tariff Clock Ticks, Fed Likely To Keep Rates Unchanged
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket